23 May 2013
Keywords: profit, soars, osi, income, tax, credit, usa
Article | 02 March 2009
The USA's OSI Pharmaceuticals has increased its 2008 profit more than six-fold, year-on-year, due to $336.0-million income tax benefit in the
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
2 March 2009
22 May 2013
© 2013 thepharmaletter.com